(Press-News.org) When delivered intranasally, vaccine was found to be more effective
Funding will support future clinical trials to test effectiveness in humans
PROVIDENCE, R.I. – A new study led by researchers at Rhode Island Hospital in collaboration with the University of Rhode Island (URI) and EpiVax. Inc, a privately owned vaccine development company in Providence, RI, has identified a potential vaccine capable of reducing colonization of Helicobacter pylori (H. pylori) -- a known cause of gastritis, ulcer disease and cancer. Their findings appear online in advance of print in the journal Vaccine.
Because the colonization of H. pylori has far-reaching health consequences, it represents a significant public health challenge. Current treatments use multiple antibiotics in combination with acid suppression medications to eradicate it. Due to an increase in antibiotic resistance, it is now more difficult to eliminate, and the development of a vaccine as an alternative therapy is of increased interest.
Steven Moss, M.D., is a gastroenterologist at Rhode Island Hospital and lead author of the paper. Moss, who is also a professor of medicine at the Warren Alpert Medical School of Brown University, says, "Normal immune mechanisms fail to eradicate H.pylori, but some prophylactic and therapeutic vaccine strategies using a wide variety of H. pylori antigens have been reported to be successful. The literature, however, does not define the optimal choice of antigen or the best delivery method."
Through an animal model study, Moss and his colleagues utilized a gene-to-vaccine approach, incorporating multiple epitopes (a part of an antigen that is recognized by the immune system) and administered them both intranasally and intramuscularly. The results of the study suggest that when the vaccine was delivered intranasally it was more effective. Moss says, "We found that the multi-epitope vaccine induced a broad immune response that led to a significant reduction in H. pylori colonization."
Anne S. De Groot, M.D., initiated the HelicoVax research program in 2005 in her company, EpiVax, Inc., with funding from a National Institutes of Health small business research award. De Groot comments, "This project illustrates the power of persistence and collaboration between the biotech industry and academe, especially when it comes to emerging infectious disease vaccines."
Moss concludes, "These encouraging, though preliminary, results suggest that further development of an epitope-based mucosal vaccine against H. pylori can potentially lead to a novel approach to prevent H. pylori-associated diseases such as peptic ulcer disease and gastric cancer in humans. We are now receiving further NIH funding to continue this collaboration with URI and EpiVax and are starting to translate this approach from mice to human subjects."
Moss is also a physician with University Medicine, (www.umfmed.org), a non-profit, multi-specialty medical group practice employing many of the full-time faculty of the department of medicine of the Alpert Medical School.
###
Other researchers involved in the study with Moss include Dong Soo Lee, Woojin Kim, and Songhua Zhang of Rhode Island Hospital and Alpert Medical School; Anne S. De Groot (University of Rhode Island, EpiVax Inc. and Alpert Medical School), Leonard Moise (University of Rhode Island, and EpiVax Inc.) William Martin, of EpiVax, Inc.; Jinhee Lee of the University of Massachusetts Medical School; and Arlin Rogers of the University of North Carolina, Chapel Hill. EpiVax, Inc. is a privately owned vaccine development company in Providence, RI.
About Rhode Island Hospital
Rhode Island Hospital (www.rhodeislandhospital.org), founded in 1863, in Providence, RI, is a private, not-for-profit hospital and is the principal teaching hospital of The Warren Alpert Medical School of Brown University. A major trauma center for southeastern New England, the hospital is dedicated to being on the cutting edge of medicine and research. The hospital receives nearly $50 million each year in external research funding and is home to Hasbro Children's Hospital, the state's only facility dedicated to pediatric care. It is a founding member of the Lifespan health system.
About EpiVax:
EpiVax, Inc. is dedicated to merging traditional immunology research with computer predictions to generate new therapeutics for cancer and autoimmune diseases as well as new vaccines for infectious diseases such as HIV, TB, and hepatitis. EpiVax's software, EpiMatrix, can predict small protein sequences capable of stimulating an immune response against an entire pathogen, and is a powerful resource for the development of novel protein therapeutics. For more information about EpiVax, please visit www.epivax.com.
END
Ritalin may help improve brain function in adolescent rats that were iron deficient during infancy, according to a team of Penn State neuroscientists. This may have implications for iron-deficient human infants as well.
The researchers found that low doses of Ritalin can help improve the focus of iron-deficient rats. Higher doses proved to hurt rather than help the control animals' focus, making them hyperactive. The control rats that were not iron deficient but received low doses of Ritalin showed no positive or negative change in performance.
When children are deprived ...
Children who grow up in poverty have health problems as adults. But a new study finds that poor adolescents who live in communities with more social cohesiveness and control get some measure of protection; they're less likely to smoke and be obese as adolescents.
The new study, published in Psychological Science, a journal of the Association for Psychological Science, is part of a long-term examination of children growing up poor in rural upstate New York. The study was designed to discover, "What is it about poverty that leads to these negative outcomes?" says lead author ...
An exercise program designed by researchers at the University of Louisville for patients with severe knee arthritis improves leg strength and patients' functional ability before knee replacement surgery, according to recent report in The Journal of Strength and Conditioning Research.
The study, led by UofL's Ann Swank, Ph.D., CSCS, and Robert Topp, Ph.D., R.N., says gains from exercise before knee replacement or prehabilitation may translate into improved recovery after surgery.
"We designed this program to be easily transferred to a home environment," Swank said. ...
BATON ROUGE – Inflammation is a healthy response in reaction to potentially harmful presences in the body. But when it starts in the lungs and builds up to a full-fledged asthma attack, it can be downright deadly. Chronic inflammation has been directly associated with heart disease and other physical ailments. But LSU graduate student Nathanial Gilbert and Professor of Biological Sciences Marcia Newcomer, together with Associate Professor Sue Bartlett, have developed the first 3-D model of Human 5-Lipoxygenase, or 5-LOX, the molecule responsible for creating inflammatory ...
Australian clinical researchers have noted an extraordinary and unexpected benefit of osteoporosis treatment – that people taking bisphosphonates are not only surviving well, better than people without osteoporosis, they appear to be gaining an extra five years of life. These findings are published in the Journal of Clinical Endocrinology and Metabolism, now online.
Associate Professor Jacqueline Center and Professor John Eisman, from Sydney's Garvan Institute of Medical Research, based their findings on data from the long running Dubbo Osteoporosis Epidemiology Study.
Out ...
On Friday, Jan. 28 in Antarctica, a research team investigating the last 100,000 years of Earth's climate history reached an important milestone completing the main ice core to a depth of 3,331 meters (10,928 feet) at West Antarctic Ice Sheet Divide (WAIS). The project will be completed over the next two years with some additional coring and borehole logging to obtain additional information and samples of the ice for the study of the climate record contained in the core.
As part of the project, begun six years ago, the team, funded by the National Science Foundation (NSF), ...
It's a quick process, generates almost no waste and is extremely precise: within a few seconds, a laser beam has welded the casing and speedometer cover together – without any screws, clamps or glues whatsoever. The result is a perfect weld seam scarcely visible to the naked eye. There are no sparks or particles flying through the air during welding. What's more: the resulting heat is confined to a minimal area. This protects the material. Many industries have now turned to welding plastics with a laser.
Still, the technology has its limits; when it comes to fusing two ...
COLLEGE PARK, Md. - University of Maryland researchers have made a breakthrough in the use of visible light for making tiny integrated circuits. Though their advance is probably at least a decade from commercial use, they say it could one day make it possible for companies like Intel to continue their decades long tread of making ever smaller, faster, and cheaper computer chips.
For some 50 years, the integrated circuits, or chips, that are at the heart of computers, smart phones, and other high-tech devices have been created through a technique known as photolithography, ...
MANHATTAN, KAN. -- When you sit down to watch a new flick, whether you enjoy the movie may depend on the person sitting next to you, according to research from a Kansas State University professor. It's especially true if you are awkwardly watching a movie's steamy love scene with your parents.
"We know that most of the time people enjoy watching movies -- that's why they do it," said Richard Harris, K-State professor of psychology. "But sometimes we watch a movie that isn't what we describe as 'enjoyable.' For whatever reason, the experience is uncomfortable emotionally ...
A new study highlights inconsistencies in black box warnings - medication-related safety warnings on a drug's label - and argues for a more transparent and systematic approach to ensure these warnings are consistent across all drugs within a same category, and any additions to warnings, on the back of a drug withdrawal for example, are done within a reasonable and uniform time period. The work by Orestis Panagiotou and John Ioannidis and colleagues from the University of Ioannina School of Medicine in Greece and Stanford University School of Medicine in the USA is published ...
